Addition of Orlistat Benefits Obese Patients With T2DM

This article originally appeared here.
Share this content:
Addition of Orlistat Benefits Obese Patients With T2DM
Addition of Orlistat Benefits Obese Patients With T2DM

THURSDAY, Sept. 17, 2015 (HealthDay News) -- In overweight and obese patients with type 2 diabetes (T2D), treatment with orlistat in addition to lifestyle modifications improves outcomes, according to research published online Sept. 8 in Obesity Reviews.

N.M. Aldekhail, of the University of Glasgow in the United Kingdom, and colleagues conducted a systematic review of randomized controlled trials of orlistat in participants with a body mass index of 25 kg/m2 or higher who were diagnosed with T2D. A meta-analysis was performed on the data from 12 studies to examine the effects of orlistat on glycemic control.

The researchers found that the overall mean weight reduction at three, six, and 12 months in the orlistat group was −4.25 kg. The mean weight difference between the orlistat group and the control group was −2.1 kg, the mean HbA1c difference was −6.12 mmol mol−1, and the mean fasting blood glucose difference was −1.16 mmol L−1.

"Treatment with orlistat plus lifestyle intervention resulted in significantly greater weight loss and improved glycemic control in overweight and obese patients with type 2 diabetes compared with lifestyle intervention alone," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Some California Mosquitoes Can Carry Zika Virus

Some California Mosquitoes Can Carry Zika Virus

Aedes aegypti mosquitoes found to transmit Zika virus

Periodontal Inflammation a Risk With Tongue Piercing

Periodontal Inflammation a Risk With Tongue Piercing

And, two young females with tongue piercings have deep lingual infrabony lesions, periodontitis

Risk of OD Highest for First Days of Opioid  Benzodiazepine Use

Risk of OD Highest for First Days of ...

Five-fold increased risk of opioid-related overdose during first 90 days of concurrent use

is free, fast, and customized just for you!




Already a member?

Sign In Now »